TAK1 inhibition subverts the osteoclastogenic action of TRAIL while potentiating its antimyeloma effects

Autor: Tenshin, Hirofumi 1, 2, Teramachi, Jumpei 2, 3, Oda, Asuka 2, Amachi, Ryota 2, 4, Hiasa, Masahiro 2, 5, Bat-Erdene, Ariunzaya 2, Watanabe, Keiichiro 2, 4, Iwasa, Masami 2, Harada, Takeshi 2, Fujii, Shiro 2, Kagawa, Kumiko 2, Sogabe, Kimiko 2, Nakamura, Shingen 2, Miki, Hirokazu 6, Kurahashi, Kiyoe 2, Yoshida, Sumiko 2, Aihara, Kenichi 2, Endo, Itsuro 2, Tanaka, Eiji 4, Matsumoto, Toshio 7, Abe, Masahiro 2, *
Zdroj: In Blood Advances 14 November 2017 1(24):2124-2137
Databáze: ScienceDirect